Screening shows that these pathways mainly involve Complement and coagulation cascades, IL-17 signaling pathway, Toll-like receptor signaling pathway, Hypertrophic cardiomyopathy (HCM), Legionellosis, Dilated cardiomyopathy (DCM), Pathways in cancer, EGFR tyrosine kinase inhibitor resistance, FoxO signaling pathway, mTOR signaling pathway (Fig. 6D). This evidence concerns the gene IL17A and cancer.